IJARP

International Journal of Advanced Research and Publications (2456-9992)

High Quality Publications & World Wide Indexing!

Outcomes of Patients’ Compliance in the Management of Hypertension During COVID-19 Pandemic

Volume 5 - Issue 7, July 2022 Edition
[Download Full Paper]

Author(s)
Cresdenn Kate S. Azcarraga, Christopher R. Banez
Keywords
Compliance, COVID-19, Hypertension, Management
Abstract
Introduction: With the COVID-19 pandemic wreaking havoc on our healthcare system, now is an excellent time to evaluate the country's current public health policy. While the world has been focused on finding a solution for the pandemic, other ailments may have gone unnoticed. Hypertension, or high blood pressure, is one of them. Hypertension is one of the most common medical conditions linked to an increased risk of cardiovascular disease. It is also one of the leading causes of morbidity and mortality in some parts of the world. Due to health and economic constraints, there is a greater possibility that hypertension will not be well monitored. It is essential to review hypertensive patients' coping mechanisms regarding their health and finances and to assess if their needs are met. Methodology: The researcher employed in-print survey questionnaire forms consisting of 3 parts. Safety protocol from the health Department was followed because of the continued threat of COVID-19. The questionnaire consists of items that determine the impact of the COVID-19 pandemic on hypertensive patients. Data was treated using weighted mean, ANOVA, and t-test. Result: The computed F-values with significance values higher than the set .05 level of significance reveal insignificant results. Meanwhile, the positive r-value of 0.070 along lifestyle indicates that the older the patient, the higher is its regard to lifestyle in dealing with hypertension during the pandemic. Therefore, it showed that the outcomes of patients' compliance in managing hypertension during the COVID-19 pandemic are significantly related to the patient's age. However, it is not significantly related to other profile variables, namely gender, civil status, highest educational attainment, occupation and number of years diagnosed with hypertension. Conclusion: The respondents are able to take their maintenance medicines even during the pandemic. However, there are perceived barriers and difficulties in compliance due to restrictions in transportation and fear of contracting the virus. The results of patients' compliance with hypertension during the COVID-19 pandemic are significantly related to their age but not to other patient profile variables such as gender, civil status, highest educational attainment, occupation, or the number of years diagnosed with hypertension, according to this study.
References
[1] Goertzen M. (2017). Applying Quantitative Methods on e-book collections: Introduction to Quantitative Research and Data. Retrieved from: https://journals.ala.org/index.php/ltr/article/view/6325

[2] Sirug, W. (2011) Basic Probability and Statistics: A Step by Step Approach. Intramuros, Manila: Mindshapers Co., Inc.

[3] Atalan, A. (2020). Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Annals of Medicine and Surgery 56, 38. https://doi.org/10.1016/j.amsu.2020.06.010

[4] Bin Traiki TA, AlShammari SA, AlAli MN, Aljomah NA, Alhassan NS, Alkhayal KA, Al-Obeed OA, Zubaidi AM. Impact of COVID-19 pandemic on patient satisfaction and surgical outcomes: A retrospective and cross-sectional study. Ann Med Surg (Lond). 2020 Oct; 58:14-19. DOI: 10.1016/j.amsu.2020.08.020. Epub 2020 Aug 21. PMID: 32864124; PMCID: PMC7442049

[5] Campbell NRC, Lackland DT, Niebylski ML the World Hypertension League and International Society of Hypertension Executive Committees. High Blood Pressure: Why Prevention and Control Are Urgent and Important—A 2014 Fact Sheet from the World Hypertension League and the International Society of Hypertension. J. Clin. Hypertens. 2014; 16:551–553.

[6] Cutler DM, Summers LH (2020). The COVID-19 Pandemic and the $16 Trillion Virus. JAMA; 324(15):1495-1496. doi: 10.1001/jama.2020.19759. PMID: 33044484; PMCID: PMC7604733.

[7] Du, Y., Zhou, N., Zha, W., Lv, Y.(2020). Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases 31(3), 746. https://doi.org/10.1016/j.numecd.2020.12.009

[8] Fuller, H. and Zosel-Huseth, (2021) A. Lessons in Resilience: Initial Coping Among Older Adults During the COVID-19 Pandemic, The Gerontologist 61(1). https://doi.org/10.1093/geront/gnaa170

[9] Gasperin, D., Netuveli, G., Dias-da-Costa, J. S., & Pattussi, M. P. (2009). Effect of psychological stress on blood pressure increase: a meta-analysis of cohort studies. Cadernos de saude publica, 25(4), 715-726.

[10] Jankowska-Polanska, B., Uchmanowicz, I., Dudek, K.,Mazur, G. (2016) Relationship between patients’ knowledge and medication adherence among patients with hypertension. Patient Preference and Adherence, 10, 2437

[11] Hunt, K., Adamson, J., Hewitt, C., & Nazareth, I. (2011). Do women consult more than men? A review of gender and consultation for back pain and headache. Journal of health services research & policy, 16(2), 108–117. https://doi.org/10.1258/jhsrp.2010.009131

[12] Schäfer, I., Hansen, H., Menzel, A., Eisele, M., Tajdar, D., Lühmann, D., & Scherer, M. (2021). The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study. BMC Family Practice, 22(1), 1-10.

[13] Kazemi T, Hajihosseini M, Mashreghimoghadam H, Azdaki N, Ziaee M. Prevalence and determinants of hypertension among Iranian adults, Birjand. Iran Int J Prev Med. 2017; 8:36. http://doi.org/. https://doi.org/10.4103/ijpvm.IJPVM_103_16

[14] Kulkarni S., Jenner B., Wilkinson, I. (2020). COVID-19 and hypertension. Journal of the Renin-Angiotensin Aldosterone System 21(2), 1. https://doi.org/10.1177/1470320320927851

[15] Lyengar KP, Jain VK, Vaishya R (2020) Current situation with doctors and healthcare workers during COVID-19 pandemic in India Postgraduate Medical Journal. DOI: 10.1136/postgrad med-2020-138496

[16] Mills, K., Bundy, J., Kelly, T., Reed, J., Kearney, P., Reynolds, K., Chen, J., He, J. et al (2016). Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries. American Heart Association 134(6), 442. https://doi.org/10.1161/CIRCULATIONAHA.115.018912

[17] Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Heart Cent. 2016;11(4):159–67.

[18] Mouhtadi BB, Kanaan RMN, Iskandarani M, Rahal MK, Halat DH. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in Lebanese adults: a cross-sectional study. Glob Cardiol Sci Pract 2018;2018(1):6. http://doi.org/https://doi.org/10.21542/gcsp.2018.6.

[19] Munshi, M. N., & Sy, S. L. (2020). Management of diabetes in patients with COVID-19. The lancet. Diabetes & endocrinology, 8(8), 667–668. https://doi.org/10.1016/S2213-8587(20)30227-8

[20] Nguyen T, Duong Bang D, Wolff A. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics. Micromachines (Basel). 2020 Mar 14;11(3):306. DOI: 10.3390/mi11030306. PMID: 32183357; PMCID: PMC7142866.

[21] Polak, S., Van Gool, I., Coheen, D., von der Thüsen, J., van Paassen, J. (2020). A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Modern Pathology 33, 2128. https://doi.org/10.1038/s41379-020-0603-3

[22] Rahmawati, R., & Bajorek, B. V. (2018). Access to medicines for hypertension: a survey in rural Yogyakarta province, Indonesia. Rural and Remote Health, 18(3), 155-167.

[23] Ross, S., Walker, A. & MacLeod, M. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens 18, 607–613 (2004). https://doi.org/10.1038/sj.jhh.1001721

[24] Salkind, N. (2021). Content Validity. Sage Research Methods. https://dx.doi.org/10.4135/9781412961288.n74

[25] Seguin, M., Mendoza, J., Lasco, G., Palileo-Villanueva, L. M., Palafox, B., Renedo, A., ... & Balabanova, D. (2022). Strong structuration analysis of patterns of adherence to hypertension medication. SSM-Qualitative Research in Health, 100104.

[26] Shibata S, Arima H, Asayama K, et al. (2020) Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens Res. 2020;43(10): 1028-1046. doi:10.1038/s41440-020-0515-0.

[27] Umberson, D. (1992). Gender, marital status and the social control of health behavior. Social science & medicine, 34(8), 907-917.

[28] Vallejo,Jr. B. and Ong, R.A. (2020). Policy responses and government science advice for the COVID 19 pandemic in the Philippines: January to April 2020. Progress in Disaster Science 7, 3. https://doi.org/10.1016/j.pdisas.2020.100115

[29] Wagner, A., Valera, M., Graves, A., Lavina, S., Ross-Degnan, D. (2008). Costs of hospital care for hypertension in an insured population without outpatient medicine benefit: an observational study in the Philippines. BMC Health Services Research 8(161), 2. doi:10.1186/1472-6963-8-161

[30] Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., Xu, L., … Song, Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934–943. https://doi.org/10.1001/jamainternmed.2020.0994

[31] Zhang W., He K., Zhao H., Hu X., Yin C., Zhao X., Shi S. Association of body mass index and waist circumference with high blood pressure in older adults. BMC Geriatric. 2021; 21:1–10. DOI: 10.1186/s12877-021-02154-5.

[32] Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

[33] Zhu, H., Wei, L. & Niu, P. (2020). The novel coronavirus outbreak in Wuhan, China. Global health respond policy 5(6), 1. https://doi.org/10.1186/s41256-020-00135-6

[34] Department of Health. (2019). 99% Of Filipinos Say Medicines Are Expensive - September Ulat Ng Bayan Report. Retrieved from: https://doh.gov.ph/doh-press-release/99-percent-of-filipinos-say-medicines-are-expensive-september-ulat-ng-bayan-report

[35] Mayo Clinic. High blood pressure (hypertension). Retrieved from: https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/symptoms-causes/syc-20373410

[36] Official Gazette of the Philippines. (2020). Implementing Rules and Regulations of Section 4(aa) of Republic Act No. 11469 Otherwise known as the “Bayanihan to Heal as One Act”. Retrieved from: https://www.officialgazette.gov.ph/downloads/2020/04apr/20200401-IRR-RA-11469-RRD.pdf

[37] Official Gazette of the Philippines. (2020). RA 11464. Retrieved from: https://www.officialgazette.gov.ph/downloads/2020/09sep/20200911-RA-11494-RRD.pdf

[38] WebMD (2020). Coronavirus history. Retrieved from: https://www.webmd.com/lung/coronavirus-history

[39] World Health Organization (2021). Hypertension. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/hypertension